As part of our continued growth in the life sciences sector, we’ve joined forces with global strategy, design and construction firm Unispace Life Sciences.
This follows on from Unispace’s acquisition of BioPharma Engineering, a life sciences engineering consulting firm in 2022. The merger will deepen our industry specialisation, while also expanding our service offerings to clients at a global scale. Bulb will begin operating as ‘Unispace Life Sciences’, part of Unispace Global, with a highly experienced team dedicated to creating exciting facilities, labs and workplaces for this sector.
CEO at Unispace Life Sciences, John O’Reilly said: “We are thrilled to welcome Bulb to our growing life sciences segment. Our businesses are well aligned, we share similar values, growth ambitions, and our combined teams have a wealth of experience to offer clients.
Life sciences is one of the strongest performing sectors in the UK and to maintain business growth these firms need access to quality facilities and working environments that attract the best talent, drive innovation, and enable collaboration.
With our new team on board, we are well placed to support clients with their changing needs in a fast-moving market.”
Managing Director at Bulb, Derek Jones said: “We are excited to join a fast-growing, global business such as Unispace Life Sciences; our joined-up team of experts will be able to offer clients a much wider range of capabilities and services. We look forward to beginning our new journey as Unispace Life Sciences and continuing to deliver inspiring & sustainable work environments that address the challenges today’s life sciences businesses are facing.”